| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |